Legal Representation
Attorney
Jefferson F. Scher
USPTO Deadlines
Application History
35 eventsDate | Code | Type | Description |
---|---|---|---|
Jun 3, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Jun 3, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
May 28, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
May 5, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
May 4, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
May 4, 2025 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
May 4, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Mar 1, 2025 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
Feb 11, 2025 | CNFR | R | FINAL REFUSAL WRITTEN |
Feb 11, 2025 | GNFR | O | FINAL REFUSAL E-MAILED |
Feb 11, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
Feb 10, 2025 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Feb 9, 2025 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
Jan 13, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
Oct 23, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Oct 23, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Oct 23, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Oct 22, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Oct 22, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Oct 22, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Oct 22, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Oct 22, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Oct 22, 2024 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
Aug 12, 2024 | ATRV | O | ATTORNEY REVIEW COMPLETED |
Jul 7, 2024 | LIME | X | LIMITATION FROM THE IB - REQUEST EXAM REVIEW |
May 13, 2024 | RFNT | P | REFUSAL PROCESSED BY IB |
May 12, 2024 | LIMG | M | LIMITATION OF GOODS RECEIVED FROM IB |
Apr 24, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Apr 23, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU |
Apr 4, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Apr 3, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
Apr 1, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
Sep 12, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
Sep 8, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Sep 7, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 001
Chemical reagents for non-medical purposes; chemical reagents for scientific purposes; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; enzyme preparations for industrial purposes to identify pathogens, infections, and infectious diseases; enzymes for scientific and research purposes; nucleic acids for scientific purposes; nucleic recombinant acids for scientific purposes; acids, namely, nucleic recombinant acids to identify pathogens, infections, and infectious diseases for scientific purposes; polymerase for scientific purposes; none of the foregoing for use in promoting plant growth or in enhancing the effectiveness of plant nutrients
Class 005
Reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use to identify pathogens, infections, and infectious diseases; chemical preparations containing enzymes for medical purposes for treating infections and infectious diseases; chemical preparations containing enzymes for treating infections and infectious diseases for pharmaceutical, veterinary and medical purposes; enzyme preparations for pharmaceutical, veterinary and medical purposes; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to diagnose and identify pathogens, infections, and infectious diseases; diagnostic kits comprising diagnostic agents, preparations and substances for medical and veterinary use; diagnostic kits comprised of medical diagnostic reagents and assays for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders, all for testing of bodily fluids for use in disease detection, namely, to diagnose and identify pathogens, infections, and infectious diseases; none of the foregoing for use in or as a medicated shampoo
Class 010
Surgical, medical and veterinary apparatus and instruments for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; diagnostic testing apparatus and instruments for medical purposes, namely, for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; medical diagnostic apparatus for testing for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; point of care medical devices, namely, a device for testing for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Anatomic pathology specimen collection kit comprising glass slides, centrifuge tubes, formalin jars, coplin jars, insert to hold slides and jars, absorbent cloth, and printed instructions, all for medical use
Class 042
Scientific research in the field of genetics; scientific research in the field of genetics and genetic engineering; research and development services in the field of chemistry; scientific research in the field of chemistry; research in the field of chemistry; research laboratory analysis services in the field of chemistry; development services in the field of medical diagnostic apparatuses; design of medical diagnostic apparatuses; research in the field of molecular sciences; data analysis for scientific research purposes in the field of scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis and evaluation services, for scientific research purposes; DNA and RNA and polynucleic acid and protein sequencing, analysis and evaluation services for scientific research purposes; genome sequencing services and the analysis and evaluation of data resulting therefrom for scientific research purposes; providing reports relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services, for scientific research purposes; custom design and development of biochemical assays
Class 044
Medical services; human healthcare services in the field of diagnosis and identification of pathogens infections and infectious diseases; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services in the field of DNA and genetic testing; medical diagnostic services in the nature of medical testing and analysis; molecular diagnostics testing for medical purposes; providing medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; analysis of medical diagnostic images and medical molecular tests for medical purposes
Additional Information
Design Mark
The mark consists of the stylized wording "DERMATOPLEX".
Classification
International Classes
001
005
010
042
044